Search research articles
Contact Us
Filters
Showing results (1361-1370 of 1,421) with videos related to
Page
of 143
Sort By:
JCI Insight
|
April 28, 2021
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
Yongjun Sui, Jianping Li, Roushu Zhang, et al.
Future Oncology (London, England)
|
June 19, 2023
ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer
Thomas J Herzog, John L Hays, Joyce N Barlin, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
Overcoming host immune responses to an AAV-delivered HIV-1 bNAb in rhesus macaques mediated by co-delivery of PD-L1
Michael Kuipa, Abubakarr A Koroma, Isai Leguizamo, et al.
Nature Communications
|
April 20, 2021
Phenological shifts in lake stratification under climate change
R Iestyn Woolway, Sapna Sharma, Gesa A Weyhenmeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
Kathleen N Moore, Michael Bookman, Jalid Sehouli, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
Co-delivered PD-L1 rescues the protective efficacy mediated by an AAV-expressed HIV-1 bNAb
Michael Kuipa, Abubakarr A Koroma, Isai Leguizamo, et al.
JAMA Oncology
|
June 14, 2019
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Panagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2025
Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancer
Robert L Hollis, Austin Miller, Heather A Lankes, et al.
Nature Communications
|
November 20, 2025
Sex-specific role of the 5-HT<sub>2A</sub> receptor in psilocybin-induced extinction of opioid reward
Alaina M Jaster, Thomas M Hadlock, Belle Buzzi, et al.
Page
of 143
Search research articles
Search
Showing results (1361-1370 of 1,421) with videos related to
Sort By:
Page
of 143
JCI Insight
|
April 28, 2021
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
Yongjun Sui, Jianping Li, Roushu Zhang, et al.
Future Oncology (London, England)
|
June 19, 2023
ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer
Thomas J Herzog, John L Hays, Joyce N Barlin, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
Overcoming host immune responses to an AAV-delivered HIV-1 bNAb in rhesus macaques mediated by co-delivery of PD-L1
Michael Kuipa, Abubakarr A Koroma, Isai Leguizamo, et al.
Nature Communications
|
April 20, 2021
Phenological shifts in lake stratification under climate change
R Iestyn Woolway, Sapna Sharma, Gesa A Weyhenmeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
Kathleen N Moore, Michael Bookman, Jalid Sehouli, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
Co-delivered PD-L1 rescues the protective efficacy mediated by an AAV-expressed HIV-1 bNAb
Michael Kuipa, Abubakarr A Koroma, Isai Leguizamo, et al.
JAMA Oncology
|
June 14, 2019
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Panagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2025
Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancer
Robert L Hollis, Austin Miller, Heather A Lankes, et al.
Nature Communications
|
November 20, 2025
Sex-specific role of the 5-HT<sub>2A</sub> receptor in psilocybin-induced extinction of opioid reward
Alaina M Jaster, Thomas M Hadlock, Belle Buzzi, et al.
Page
of 143